Joanne Chory, a Salk Institute biologist widely admired by climate scientists for her efforts to get plants to absorb greater ...

The DNA synthesis market is growing as demand for DNA synthesis products and services increases across various applications, with significant growth in North America, Europe, and Asia Pacific.Austin, ...

UGC Chairman M Jagadesh Kumar says including Ayurveda Biology, which seeks to apply evidence-based methods to Ayurveda ...

Answer ALS and Cedars-Sinai have announced the completed availability of the largest ALS patient-based iPSC and bio data ...

Mori Arkin's appointment as interim CEO as of January 1, 2025 approved by shareholdersPhase 3 clinical trial of SGT-610 for Gorlin Syndrome is ...

The most likely crossword and word puzzle answers for the clue of A Single Eyebrow Created When The Two Eyebrows Meet In The ...

Novel liquid biopsy tools allowing for diagnosis and prognostic prediction for gastric cancer (GC) patients are urgently ...

Initiation of Phase 1b Study of GT-02287 in Parkinson's patients expected by end of 2024 BETHESDA, Md., Nov. 14, 2024 (GLOBE ...

-Third Subject Safely Treated with the Low-Dose of BB-301 in October 2024, and Fourth Subject Expected to Receive Treatment with the Low-Dose of BB-301 in December 2024 ...

Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...

Mori Arkin's appointment as interim CEO as of January 1, 2025 approved by shareholdersPhase 3 clinical trial of SGT-610 for Gorlin Syndrome is ongoing with over 40 clinical sites activatedSGT-210 proo ...